Course Directors:
Bridget Mattson, PharmD and Kristine Steffen, PharmD, PhD

*Up to 4 CE credits are available.*

Course Overview and Target Audience:
The pharmacology course involves a combined clinical practice and research-focused approach to discussing pharmacotherapy and pharmacokinetic considerations relevant to the bariatric surgery patient. The first part of the course is designed to provide an overview of pharmaceutical care for the bariatric surgery patient.  The role of the pharmacist in the overall management of patient care will be discussed, along with the process of conducting a drug evaluation for a bariatric surgery patient.  Pharmacotherapy considerations in the pre-operative, peri-operative, and post-operative time-periods will be addressed, as well as issues related to impaired or enhanced drug absorption, discussion of the potential mechanisms underlying these changes, vitamin and mineral supplementation and potential drug-vitamin interactions to avoid.  The second portion of the course will describe the limited research conducted in the area of bariatric surgery and pharmacokinetics, discuss research needs in this area, and present data recently collected on antidepressants and describe how these data may relate to psychiatric outcomes in bariatric surgery patients. This course is designed for Integrated Health members and physicians involved with the pharmaceutical care of bariatric patients, including pharmacists, nurses, all other allied health professionals and physicians.

Course Objectives:
Upon completion of the activity, with regards to the bariatric surgery patient, participants should be able to:

• Describe the role of the pharmacist in each phase of care
• Define potential mechanisms impacting drug absorption
• Restate the process for conducting a drug evaluation
• Discuss pharmaceutical considerations for vitamins/supplements
• Explain study design and research needs
• Summarize recent data on antidepressants and how it may relate to psychiatric outcomes

Course Outline:

7:00am
Registration

8:00am
Welcome and Introduction – Bridget Mattson, PharmD and Kristine Steffen, PharmD, PhD

8:05am
The Role Pharmacist on the Bariatric Team: Pre-Op, Peri-Op and Post-Op  – April Smith, PharmD, BCPS; Jennifer Catella, PharmD, BCPS; Bridget Mattson, PharmD

8:35am
Drug Absorption Issues/Mechanisms – April Smith, PharmD, BCPS

8:55am
Conducting a Drug Evaluation for the Bariatric Patient – Bridget Mattson, PharmD

9:10am
Pharmaceutical Considerations with Vitamins/Supplements – Jennifer Catella, PharmD, BCPS

9:30am
Refreshment Break in the Expo Center

10:15am
Study Design & Upcoming Research Needs for Bariatric Patients – Kristine Steffen, PharmD, PhD

10:30am
Review of Data Collected for Neuropsychiatric Research Institute To Date & Clinical Implications of Data on Psychiatric Outcomes – James Mitchell, MD

11:15am
Pharmacy Consult Services: Current Practices and Outcomes – April Smith, PharmD, BCPS; Jennifer Catella, PharmD, BCPS; Bridget Mattson, PharmD

11:30am
Case Studies – All Faculty

11:45am
Panel Q&A – All Faculty

12:00pm
Adjourn